West Family Investments Inc. bought a new position in shares of Relx Plc (NYSE:RELX - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 5,966 shares of the technology company's stock, valued at approximately $301,000.
Several other institutional investors have also recently made changes to their positions in RELX. Golden State Wealth Management LLC boosted its holdings in Relx by 100.0% in the 1st quarter. Golden State Wealth Management LLC now owns 588 shares of the technology company's stock valued at $30,000 after purchasing an additional 294 shares during the period. Cornerstone Planning Group LLC boosted its holdings in Relx by 325.2% in the 1st quarter. Cornerstone Planning Group LLC now owns 693 shares of the technology company's stock valued at $37,000 after purchasing an additional 530 shares during the period. Transce3nd LLC bought a new position in Relx in the 4th quarter valued at $40,000. Brown Brothers Harriman & Co. boosted its holdings in Relx by 218.5% in the 4th quarter. Brown Brothers Harriman & Co. now owns 965 shares of the technology company's stock valued at $44,000 after purchasing an additional 662 shares during the period. Finally, Redwood Investments LLC bought a new position in Relx in the 4th quarter valued at $120,000. Hedge funds and other institutional investors own 15.02% of the company's stock.
Relx Trading Up 1.2%
NYSE RELX traded up $0.63 during trading on Wednesday, hitting $53.81. 1,419,930 shares of the company's stock traded hands, compared to its average volume of 753,715. The stock has a fifty day moving average of $53.71 and a two-hundred day moving average of $50.97. The company has a debt-to-equity ratio of 1.46, a current ratio of 0.52 and a quick ratio of 0.47. Relx Plc has a 12-month low of $43.45 and a 12-month high of $56.33. The firm has a market cap of $98.84 billion, a P/E ratio of 28.91, a PEG ratio of 3.25 and a beta of 0.83.
Wall Street Analyst Weigh In
A number of research firms have commented on RELX. Morgan Stanley reissued an "overweight" rating on shares of Relx in a research note on Wednesday, April 16th. The Goldman Sachs Group began coverage on shares of Relx in a research note on Wednesday, March 26th. They issued a "buy" rating for the company. Finally, Wall Street Zen cut shares of Relx from a "buy" rating to a "hold" rating in a research note on Saturday. One equities research analyst has rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, Relx presently has a consensus rating of "Buy".
Read Our Latest Stock Report on Relx
About Relx
(
Free Report)
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
See Also
Before you consider Relx, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Relx wasn't on the list.
While Relx currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
